Accel, Aarin put fresh funds in biotech startup led by former Biocon execs

By Joseph Rai

  • 23 Aug 2017
Premium

Venture capital firms Accel Partners and Aarin Capital have invested fresh funds in a biotechnology firm led by the former executives of Biocon, two people familiar with the development told VCCircle.Bangalore-based Sayre Therapeutics which was founded in 2015, has raised another Rs 27.5 crore ($4.2 million) in follow-on funding from ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.